Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ondansetron (4mg) + Rabeprazole (20mg)
Therapeutic Category
Gastroenterology, Antacid
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹92/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ribziff OXT Tablet is a combination medication containing Ondansetron (4mg) and Rabeprazole (20mg), designed to manage and prevent nausea and vomiting associated with various conditions, such as chemotherapy, radiation therapy, and surgery, while also promoting better digestion and relieving symptoms of acid reflux.
Ondansetron (4mg) is a potent antiemetic that blocks serotonin receptors in the brain to prevent nausea and vomiting, while Rabeprazole (20mg) is a proton pump inhibitor that reduces stomach acid production, helping in the treatment of acid-related conditions like GERD (gastroesophageal reflux disease).
Possible side effects include headache, constipation, dizziness, or mild gastrointestinal discomfort.
Prevents nausea and vomiting associated with chemotherapy, surgery, and radiation, and treats acid reflux.
Consult a doctor before use, especially if pregnant, breastfeeding, or if you have any pre-existing medical conditions.
Store in a cool, dry place, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Ondansetron (8 mg) MD
Composition : Ondansetron (4mg) MD
Composition : Ondansetron (2mg)
Composition : Granisetron (1mg) Injection
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Tranexamic Acid (500mg) Injection
Composition : Tranexamic Acid (500mg)
Composition : Tranexamic Acid (250mg) + Ethamsylate (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the gastroenterology, hospital care, emergency care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-emetic and acid-peptic disorder portfolios.
Medical distributors and agencies can benefit from consistent demand for vomiting with acidity and gastric disorder management under medical supervision. Ondansetron 4mg is an anti-emetic that controls nausea and vomiting Rabeprazole 20mg is a proton pump inhibitor that reduces gastric acid secretion Commonly prescribed for gastritis, acid reflux (GERD), acidity with nausea, post-operative vomiting, and gastrointestinal infections with gastric irritation Provides dual benefit: controls vomiting + reduces acid-related discomfort Widely prescribed by physicians, gastroenterologists, surgeons, and general practitioners This strengthens a comprehensive gastro care and anti-emetic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ondansetron 4mg + Rabeprazole 20mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand in gastro and hospital segments, repeat orders, reliable supply chain support, and attractive margins in the anti-emetic and PPI segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business